ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions

Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels

Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062

Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

Halliwell, B. B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,926

Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate

Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534

Cellular defenses against damage from reactive oxygen species

Yu, B. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.1.139 · Cited by 2,382

Localization of neuronal and glial glutamate transporters

Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703

Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase

Deng, H., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,479

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471

Interaction between Familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 Mutants and the Dynein Complex

Zhang, F., Ström, A., Fukada, K., Lee, S., Hayward, L. J., & Zhu, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609743200 · Cited by 187

New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes

Kato, S., Takikawa, M., Nakashima, K., Hirano, A., Cleveland, D. W., Kusaka, H., Shibata, N., Kato, M., Nakano, I., & Ohama, E. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515160 · Cited by 180

Variation in the Biochemical/Biophysical Properties of Mutant Superoxide Dismutase 1 Enzymes and the Rate of Disease Progression in Familial Amyotrophic Lateral Sclerosis Kindreds

Ratovitski, T., Corson, L., Strain, J., Wong, P., Cleveland, D. W., Culotta, V., & Borchelt, D. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1451 · Cited by 180

The endocannabinoid system as a target for the treatment of neurodegenerative disease

Scotter, E. L., Abood, M. E., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00735.x · Cited by 188

Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death

Rossi, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.04.003 · Cited by 185

Focal degeneration of astrocytes in amyotrophic lateral sclerosis

Rossi, D., Brambilla, L., Valori, C. F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D. E., & Volterra, A. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.99 · Cited by 194

Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS

Alexander, G. M., Erwin, K. L., Byers, N., Deitch, J. S., Augelli, B. J., Blankenhorn, E. P., & Heiman-Patterson, T. D. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.07.002 · Cited by 176

Enhancing Mitochondrial Calcium Buffering Capacity Reduces Aggregation of Misfolded SOD1 and Motor Neuron Cell Death without Extending Survival in Mouse Models of Inherited Amyotrophic Lateral Sclerosis

Parone, P. A., Cruz, S. D., Han, J. S., McAlonis‐Downes, M., Vetto, A. P., Lee, S. K., Tseng, E., & Cleveland, D. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1119-12.2013 · Cited by 188

Inflammation and neurovascular changes in amyotrophic lateral sclerosis

Evans, M. C., Couch, Y., Sibson, N. R., & Turner, M. R. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.008 · Cited by 174

Antioxidant and Cell‐Signaling Functions of Hydrogen Sulfide in the Central Nervous System

Shefa, U., Kim, M., Jeong, N. Y., & Jung, J. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1873962 · Cited by 176

The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)

Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172

Synaptic pathology: A shared mechanism in neurological disease

Henstridge, C. M., Pickett, E. K., & Spires‐Jones, T. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.005 · Cited by 176

Amyotrophic Lateral Sclerosis-linked Glutamate Transporter Mutant Has Impaired Glutamate Clearance Capacity

Trotti, D., Aoki, M., Pasinelli, P., Berger, U. V., Danbolt, N. C., Brown, R. H., & Hediger, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003779200 · Cited by 174

The role of p53 in neuronal cell death

Morrison, R. S., & Kinoshita, Y. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400741 · Cited by 175

Current approaches to enhance glutamate transporter function and expression

Fontana, A. C. K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13200 · Cited by 179

Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities

Magrané, J., Hervías, I., Henning, M. S., Damiano, M. G., Kawamata, H., & Manfredi, G. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp421 · Cited by 171

Intercellular (Mis)communication in Neurodegenerative Disease

Garden, G. A., & Spada, A. R. L. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.017 · Cited by 176

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

Turner, M. R., Bowser, R. P., Bruijn, L. I., Dupuis, L., Ludolph, A. C., McGrath, M. S., Manfredi, G., Maragakis, N. J., Miller, R. G., Pullman, S. L., et al. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.778554 · Cited by 168

Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models

Zetterström, P., Stewart, H. G., Bergemalm, D., Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brännström, T., Oliveberg, M., & Marklund, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700477104 · Cited by 170

Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons

Ackerley, S., Grierson, A. J., Brownlees, J., Thornhill, P., Anderton, B. H., Leigh, P. N., Shaw, C. E., & Miller, C. C. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.1.165 · Cited by 170

Activated Microglia Initiate Motor Neuron Injury by a Nitric Oxide and Glutamate-Mediated Mechanism

Zhao, W., Xie, W., Le, W., Beers, D. R., He, Y., Henkel-Tigges, J., Simpson, E. P., Yen, A. A., Xiao, Q., & Appel, S. H. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.964 · Cited by 169

Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis

Rao, S. D., & Weiss, J. H. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.11.001 · Cited by 168

A Drosophila Model for Amyotrophic Lateral Sclerosis Reveals Motor Neuron Damage by Human SOD1

Watson, M. R., Lagow, R. D., Xu, K., Zhang, B., & Bonini, N. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804817200 · Cited by 176

The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development

Blasco, H., Mavel, S., Corcia, P., & Gordon, P. H. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140916120118 · Cited by 165

Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis

Liu, R., Althaus, J. S., Ellerbrock, B. R., Becker, D. A., & Gurney, M. E. (1998) · Annals of Neurology · doi:10.1002/ana.410440510 · Cited by 165

A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease

Ramesh, T., Lyon, A. N., Pineda, R., Wang, C., Janssen, P. M. L., Canan, B. D., Burghes, A. H. M., & Beattie, C. E. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005538 · Cited by 164

Overexpression of HGF Retards Disease Progression and Prolongs Life Span in a Transgenic Mouse Model of ALS

Sun, W., Funakoshi, H., & Nakamura, T. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06537.2002 · Cited by 164

Transgenic mouse models of amyotrophic lateral sclerosis

Julien, J., & Križ, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.006 · Cited by 162

Structural properties and neuronal toxicity of amyotrophic lateral sclerosis–associated Cu/Zn superoxide dismutase 1 aggregates

Matsumoto, G., Stojanovic, A., Holmberg, C. I., Kim, S., & Morimoto, R. I. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504050 · Cited by 168

RNA-binding proteins with prion-like domains in ALS and FTLD-U

Gitler, A. D., & Shorter, J. (2011) · Prion · doi:10.4161/pri.5.3.17230 · Cited by 167

Cell Cycle Regulators in the Neuronal Death Pathway of Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase 1

Nguyen, M. D., Boudreau, M., Križ, J., Couillard‐Després, S., Kaplan, D. R., & Julien, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02131.2003 · Cited by 159

ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis

Kanekura, K., Suzuki, H., Aiso, S., & Matsuoka, M. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8054-3 · Cited by 162

SOD1 in Amyotrophic Lateral Sclerosis: “Ambivalent” Behavior Connected to the Disease

Pansarasa, O., Bordoni, M., Diamanti, L., Sproviero, D., Gagliardi, S., & Cereda, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051345 · Cited by 170

Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants

Corson, L., Strain, J. J., Culotta, V., & Cleveland, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6361 · Cited by 160

Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis†

Cheroni, C., Marino, M., Tortarolo, M., Veglianese, P., Biasi, S. D., Fontana, E., Vitellaro‐Zuccarello, L., Maynard, C. J., Dantuma, N. P., & Bendotti, C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn319 · Cited by 167

Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production

McGivern, J. V., Patitucci, T. N., Nord, J. A., Barabas, M. E., Stucky, C. L., & Ebert, A. D. (2013) · Glia · doi:10.1002/glia.22522 · Cited by 156

Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro

Lee, M., Ban, J.-J., Kim, K.-Y., Jeon, G. S., Im, W., Sung, J., & Kim, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.069 · Cited by 157

Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial

Baloh, R. H., Johnson, J. P., Avalos, P., Allred, P., Svendsen, S. P., Gowing, G., Roxas, K., Wu, A., Donahue, B., Osborne, S., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01956-3 · Cited by 157

Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications

Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156

Rodent models of amyotrophic lateral sclerosis

McGoldrick, P., Joyce, P. I., Fisher, E., & Greensmith, L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.012 · Cited by 162

Ferroptosis in Neurological Diseases

Ren, J., Sun, X., Yan, X., Guo, Z., & Yang, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00218 · Cited by 163

Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS

Lee, J.-H., Hyeon, S. J., Im, H., Ryu, H., Kim, Y., & Ryu, H. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.5.233 · Cited by 160

Protein precipitation: a common etiology in neurodegenerative disorders?

Kakizuka, A. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01559-5 · Cited by 152

Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis

Kabashi, E., Agar, J. N., Taylor, D. M., Minotti, S., & Durham, H. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02453.x · Cited by 165

Intricate interplay between astrocytes and motor neurons in ALS

Phatnani, H. P., Guarnieri, P., Friedman, B. A., Carrasco, M. A., Muratet, M. A., O’Keeffe, S., Nwakeze, C. L., Pauli, F., Newberry, K. M., Meadows, S. K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222361110 · Cited by 151

AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis

Kim, K., Moore, D. H., Makriyannis, A., & Abood, M. E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.025 · Cited by 152

Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition

Yu, A., Shibata, Y., Shah, B., Calamini, B., Lo, D. C., & Morimoto, R. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321811111 · Cited by 152

From animal models to human disease: a genetic approach for personalized medicine in ALS

Picher‐Martel, V., Valdmanis, P. N., Gould, P. V., Julien, J., & Dupré, N. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0340-5 · Cited by 163

Structural Characterization of Zinc-deficient Human Superoxide Dismutase and Implications for ALS

Roberts, B. R., Tainer, J. A., Getzoff, E. D., Malencik, D. A., Anderson, S. R., Bomben, V. C., Meyers, K. R., Karplus, P. A., & Beckman, J. S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.043 · Cited by 151

Misfolded SOD1 Associated with Motor Neuron Mitochondria Alters Mitochondrial Shape and Distribution Prior to Clinical Onset

Velde, C. V., McDonald, K. K., Boukhedimi, Y., McAlonis‐Downes, M., Lobsiger, C. S., Hadj, S. B., Zandona, A., Julien, J., Shah, S. B., & Cleveland, D. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022031 · Cited by 167

Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice—a model of familial amyotrophic lateral sclerosis

Poon, H. F., Hensley, K., Thongboonkerd, V., Merchant, M. L., Lynn, B. C., Pierce, W. M. J., Klein, J. B., Calabrese, V., & Butterfield, D. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.030 · Cited by 148

Glutamate Transporter EAAT2: A New Target For The Treatment Of Neurodegenerative Diseases

Lin, C. G., Kong, Q., Cuny, G. D., & Glicksman, M. A. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.122 · Cited by 154

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers

Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147

Programmed cell death in amyotrophic lateral sclerosis

Guégan, C., & Przedborski, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17610 · Cited by 146

Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration

Henstridge, C. M., Tzioras, M., & Paolicelli, R. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00063 · Cited by 155

Complex Tissue and Disease Modeling using hiPSCs

Passier, R., Orlova, V., & Mummery, C. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.011 · Cited by 142

Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS

Wang, J., Farr, G. W., Zeiss, C. J., Rodriguez‐Gil, D. J., Wilson, J. H., Furtak, K., Rutkowski, D. T., Kaufman, R. J., Ruse, C. I., Yates, J. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813045106 · Cited by 147

Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood–brain barrier and knock down genes in the rodent CNS

Nagata, T., Dwyer, C. A., Yoshida‐Tanaka, K., Ihara, K., Ohyagi, M., Kaburagi, H., Miyata, H., Ebihara, S., Yoshioka, K., Ishii, T., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00972-x · Cited by 142

Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons

Lobsiger, C. S., Boillée, S., & Cleveland, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702230104 · Cited by 139

Leech giant glial cell: functional role in a simple nervous system

Deitmer, J. W., Rose, C. R., Munsch, T., Schmidt, J., Nett, W., Schneider, H.-P., & Lohr, C. (1999) · Glia · doi:10.1002/(sici)1098-1136(199912)28:3 · Cited by 43

Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences

Kato, S. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0308-4 · Cited by 139

Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis

Graffmo, K. S., Forsberg, K., Bergh, J., Birve, A., Zetterström, P., Andersen, P. M., Marklund, S. L., & Brännström, T. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds399 · Cited by 145

Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons

Subramanian, V., Crabtree, B., & Acharya, K. R. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm290 · Cited by 139

Overview of Glutamatergic Dysregulation in Central Pathologies

Miladinovic, T., Nashed, M. G., & Singh, G. (2015) · Biomolecules · doi:10.3390/biom5043112 · Cited by 145

Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis

Almad, A. A., Doreswamy, A., Gross, S. K., Richard, J., Huo, Y., Haughey, N. J., & Maragakis, N. J. (2016) · Glia · doi:10.1002/glia.22989 · Cited by 146

Disease mechanisms revealed by transcription profiling in SOD1‐G93A transgenic mouse spinal cord

Olsen, M. K., Roberds, S. L., Ellerbrock, B. R., Fleck, T. J., McKinley, D. K., & Gurney, M. E. (2001) · Annals of Neurology · doi:10.1002/ana.1252 · Cited by 137

Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis

Pieri, M., Carunchio, I., Curcio, L., Mercuri, N. B., & Zona, C. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.002 · Cited by 137

Review: Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy

Murray, L. M., Talbot, K., & Gillingwater, T. H. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01061.x · Cited by 140

Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease

Tikka, T., Vartiainen, N. E., Goldsteins, G., Oja, S. S., Andersen, P. M., Marklund, S. L., & Koıstınaho, J. (2002) · Brain · doi:10.1093/brain/awf068 · Cited by 136

Motor Neuron Degeneration Promotes Neural Progenitor Cell Proliferation, Migration, and Neurogenesis in the Spinal Cords of Amyotrophic Lateral Sclerosis Mice

Chi, L.-Y., Ke, Y., Luo, C., Li, B.-L., Gozal, D., Kalyanaraman, B., & Liu, R.-G. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0076 · Cited by 134

Astrogliosis in Amyotrophic Lateral Sclerosis: Role and Therapeutic Potential of Astrocytes

Vargas, M. R., & Johnson, J. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.012 · Cited by 145

Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid

Raman, C., McAllister, S. D., Rizvi, G., Patel, S., Moore, D. H., & Abood, M. E. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310016813 · Cited by 133

Protein aggregation in motor neurone disorders

Wood, J. D., Beaujeux, T. P., & Shaw, P. J. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00518.x · Cited by 137

Inflammation in ALS and SMA: Sorting out the good from the evil

Papadimitriou, D. A., Verche, V. L., Jacquier, A., Ikiz, B., Przedborski, S., & Ré, D. B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 137

β-Secretase-Cleaved Amyloid Precursor Protein Accumulates at Actin Inclusions Induced in Neurons by Stress or Amyloid β: A Feedforward Mechanism for Alzheimer's Disease

Maloney, M. T., Minamide, L. S., Kinley, A. W., Boyle, J. A., & Bamburg, J. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3711-05.2005 · Cited by 140

The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study

Fray, A. E., Ince, P. G., Banner, S. J., Milton, I. D., Usher, P., Cookson, M., & Shaw, P. J. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00273.x · Cited by 132

SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments

Joyce, P. I., Fratta, P., Fisher, E., & Acevedo‐Arozena, A. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9339-1 · Cited by 139

The unfolded protein response in familial amyotrophic lateral sclerosis

Wang, L., Popko, B., & Roos, R. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq546 · Cited by 132

Mechanisms of SOD1 regulation by post-translational modifications

Banks, C. J., & Andersen, J. L. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101270 · Cited by 133

Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice

Kieran, D., Woods, I., Villunger, A., Strasser, A., & Prehn, J. H. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707906105 · Cited by 134

Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin‐1β in neurodegeneration

Nguyen, M. D., Julien, J., & Rivest, S. (2001) · Annals of Neurology · doi:10.1002/ana.1256 · Cited by 129

Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis

Obrador, E., Palmer, R. S., López‐Blanch, R., Jihad-Jebbar, A., Vallés, S. L., & Estrela, J. M. (2020) · Antioxidants · doi:10.3390/antiox9090901 · Cited by 132

Programmed cell death in amyotrophic lateral sclerosis

Guégan, C., & Przedborski, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317610 · Cited by 128

High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal

Wataya, T., Nunomura, A., Smith, M. A., Siedlak, S. L., Harris, P. L. R., Shimohama, S., Szweda, L. I., Kaminski, M. A., Ávila, J., Price, D. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110913200 · Cited by 128

The ubiquitin proteasome system in glia and its role in neurodegenerative diseases

Jansen, A. H. P., Reits, E. A., & Hol, E. M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00073 · Cited by 133

Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS

Weskamp, K., Tank, E. M. H., Miguez, R., McBride, J. P., Gómez, N., White, M. A., Lin, Z., Moreno-Gonzalez, C., Serio, A., Sreedharan, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130988 · Cited by 131

Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis

Harten, A. C. M. V., Phatnani, H. P., & Przedborski, S. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.04.008 · Cited by 123

Rodent models of TDP-43: Recent advances

Tsao, W., Jeong, Y. H., Lin, S. Z., Ling, J. P., Price, D. L., Chiang, P., & Wong, P. C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.031 · Cited by 129

Diversity of astroglial responses across human neurodegenerative disorders and brain aging

Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12538 · Cited by 135

Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS

Robertson, J., Sanelli, T. R., Xiao, S., Yang, W., Horne, P., Hammond, R. R., Pioro, E. P., & Strong, M. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.066 · Cited by 125

The Copper Chaperone CCS Is Abundant in Neurons and Astrocytes in Human and Rodent Brain

Rothstein, J. D., Dykes‐Hoberg, M., Corson, L., Becker, M., Cleveland, D. W., Price, D. L., Culotta, V., & Wong, P. C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720422.x · Cited by 125

Regulation and Dysregulation of Glutamate Transporters

Sattler, R., & Rothstein, J. D. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_14 · Cited by 127

Impaired Spinal Cord Glutamate Transport Capacity and Reduced Sensitivity to Riluzole in a Transgenic Superoxide Dismutase Mutant Rat Model of Amyotrophic Lateral Sclerosis

Dunlop, J., McIlvain, H. B., She, Y., & Howland, D. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01688.2003 · Cited by 124

Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo

Qian, K. X., Huang, H., Peterson, A., Hu, B., Maragakis, N. J., Ming, G., Chen, H., & Zhang, S. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.003 · Cited by 128

Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation

Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Ferrante, K. L., Bogdanov, M. B., Kaddurah-Daouk, R. F., & Beal, M. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00188.x · Cited by 123

Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice

Tobisawa, S., Hozumi, Y., Arawaka, S., Koyama, S., Wada, M., Nagai, M., Aoki, M., Itoyama, Y., Goto, K., & Kato, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00353-x · Cited by 128

Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: αB-crystallin modulates aggregation

Wang, J., Xu, G. M., Li, H., Gonzales, V., Fromholt, D., Karch, C. M. M., Copeland, N. G., Jenkins, N. A., & Borchelt, D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi236 · Cited by 123

Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis

Bories, C., Amendola, J., d’Incamps, B. L., & Durand, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05306.x · Cited by 122

Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice

Pardo, A. C., Wong, V., Benson, L. M., Dykes, M., Tanaka, K., Rothstein, J. D., & Maragakis, N. J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.028 · Cited by 122

Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS

Lepore, A. C., Haenggeli, C., Gasmi, M., Bishop, K. M., Bartus, R. T., Maragakis, N. J., & Rothstein, J. D. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.034 · Cited by 121

Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice

Wang, L., Gutmann, D. H., & Roos, R. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq463 · Cited by 214

SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis

Wallis, N., Lau, C. L., Farg, M. A., Atkin, J. D., Beart, P. M., & O’Shea, R. D. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2385-7 · Cited by 14

Issue Cover (October 2015)

(2015) · Journal of Neurochemistry · doi:10.1111/jnc.12905

Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration

Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., & Elliott, J. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00660.2000 · Cited by 387

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Swami, M. (2011) · Nature Medicine · doi:10.1038/nm.2484 · Cited by 33